This federal contract award, identified as SPE2DB22D3301|SPE2DB25FX6DV, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 100-count bottles of 5 mg oxycodone hydrochloride immediate-release tablets, with a ceiling value of $1,166.60 and a completion date of November 27, 2024.
The contract is a delivery order, with a firm fixed-price pricing type. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp, the prime contractor, is a for-profit organization that is registered in the System for Award Management (SAM.gov) and plays a critical role in supplying medical products to federal government agencies, particularly within military and veterans' healthcare systems.
In addition to this specific contract, Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Generated 2/25/25, 9:50 AM